Vor Biopharma: Pay

Vor Biopharma paid its 4 named executives $119.6M in total in FY2025 (Dec). CEO Jean-Paul Kress was paid $65.0M of that.

Pay$100 in the stock at the end of FY24 → $59

CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Jean-Paul KressPresident, Chief Executive Officer and Chairman


FY2025 (Dec)

1 year

Sandesh MahatmeChief Financial Officer


FY2025 (Dec)

1 year

Qing ZurawFormer Chief Development Officer


FY2025 (Dec)

1 year

Robert AngFormer President and Chief Executive Officer


FY2025 (Dec)
FY2022 (Dec)

2 years

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.